Hap Trading, LLC Macrogenics Inc Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$3.31 - $18.51 $248,250 - $1.39 Million	75,000 New	75,000 $15 Million
Q3 2019 Nov 12, 2019	SELL	$12.44 - $17.48 $771,280 - $1.08 Million	-62,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$14.51 - $19.71 $14,510 - $19,710	-1,000 Reduced 1.59%	62,000 $1,000
Q1 2019 May 10, 2019	BUY	$11.11 - $25.6 $699,930 - $1.61 Million	63,000 New	63,000 $33,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.